NVAX

NOVAVAX INC

Biotechnology · Biotechnology

$256.69 sample

+4.62 (+1.83%) 1D

Market cap

$1.09T

Price as of

2026-10-04

Latest filing

8-K · 2026-08-12

Alerts

8

Price$256.69 +16.20% 3M daily closessample

256.69217.15

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider buy: EVP, Operations
Sep 18INSInsider buy: EVP, Operations
Sep 15INSInsider buy: General Counsel
Sep 04INSInsider sell: Chief Financial Officer
Aug 26INSInsider buy: EVP, Operations
Aug 18INSInsider sell: General Counsel
Aug 12SECForm 144 filed
Aug 06SEC8-K filed: material event

Sign up to see the real NVAX record →

Company facts

SEC EDGAR registration

Name: NOVAVAX INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -7sample, -100 to +100
Reporting currency: USD

Who is positioning in NVAX

sample

Insiders: 18 insider transactions over 90 days, net selling, $343.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 43 funds hold $9.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$73.6B +24.2% y/y

Q4 2024Q3 2026

Inventory$40.9B +13.0% y/y

Q4 2024Q3 2026

Accounts receivable$31.2B +14.6% y/y

Q4 2024Q3 2026

Total debt$84.4B +9.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $288.6B +8.1% 3M
Sample peer B: $251.8B +10.2% 3M
Sample peer C: $399.3B +3.9% 3M
Sample peer D: $1.04T +14.8% 3M
Sample peer E: $806.7B -5.6% 3M